State MO
Clinical Trials in Missouri
Recruiting clinical trials with at least one study location in Missouri. Data updated daily from ClinicalTrials.gov.
Top Conditions in Missouri
NCT05558371 N/A
Recruiting
International CDKL5 Clinical Research Network
Condition
CDKL5
Enrollment
1,000 pts
Location
United States, Australia
Sponsor
University of Colorado, Denver
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT05462704 Phase 3
Recruiting
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
Condition
Iron Deficiency Anemia
Enrollment
300 pts
Location
United States
Sponsor
Women and Infants Hospital of
NCT04929028 Phase 2
Recruiting
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Condition
AIDS-Related Anal Carcinoma
Enrollment
40 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06787066 EARLY_Phase 1
Recruiting
Sympathetic Vascular Transduction Across the Menopause Transition: Contributing ...
Condition
Menopause
Enrollment
75 pts
Location
United States
Sponsor
University of Missouri-Columbi
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT03016819 Phase 3
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarco...
Condition
Alveolar Soft Part Sarcoma
Enrollment
325 pts
Location
United States, China, Italy
Sponsor
Advenchen Laboratories, LLC
NCT04951622 Phase 3
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Condition
Myasthenia Gravis
Enrollment
199 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT06859801 N/A
Recruiting
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Tre...
Condition
Bone Cancer Metastatic
Enrollment
120 pts
Location
United States
Sponsor
Society of Interventional Onco
NCT04704661 Phase 1
Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The ...
Condition
Advanced Breast Carcinoma
Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endo...
Condition
Endometrial Cancer
Enrollment
268 pts
Location
United States, Austria, Canada
Sponsor
Kartos Therapeutics, Inc.
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT06402331 Phase 2
Recruiting
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
Fusion Pharmaceuticals Inc.
NCT06941272 Phase 1, Phase 2
Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
50 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT07226895 Phase 1, Phase 2
Recruiting
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT198...
Condition
Clinical High Risk for Psychosis (CHR)
Enrollment
150 pts
Location
United States
Sponsor
Monument Therapeutics Limited
NCT04703842 Phase 1, Phase 2
Recruiting
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure Wit...
Condition
Congestive Heart Failure
Enrollment
57 pts
Location
United States
Sponsor
Sardocor Corp.
NCT06840483 Phase 2
Recruiting
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
Condition
Breast Cancer
Enrollment
66 pts
Location
United States, Australia, Belgium
Sponsor
BicycleTx Limited
NCT03118986 Phase 2
Recruiting
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Che...
Condition
Vomiting in Infants and/or Children
Enrollment
200 pts
Location
United States, Canada, India
Sponsor
The Hospital for Sick Children
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT03424850 Phase 1, Phase 2
Recruiting
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate ...
Condition
Prostate Cancer
Enrollment
36 pts
Location
United States
Sponsor
Washington University School o
NCT05587569 N/A
Recruiting
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
Condition
Metatarsus Adductus
Enrollment
80 pts
Location
United States
Sponsor
Treace Medical Concepts, Inc.
NCT07114601 Phase 1
Recruiting
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Condition
Breast Neoplasms
Enrollment
421 pts
Location
United States, Canada, France
Sponsor
Eli Lilly and Company
NCT05863195 Phase 3
Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus St...
Condition
Metastatic Colorectal Carcinoma
Enrollment
408 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals